{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:04:49Z","timestamp":1777586689860,"version":"3.51.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Activation of the renin angiotensin system plays a pivotal role in the regulation of blood pressure, which is mainly attributed to the formation of angiotensin-II (Ang II). The actions of Ang II are mediated through binding to the Ang-II type 1 receptor (AT1R) which leads to increased blood pressure, fluid retention, and aldosterone secretion. In addition, Ang II is also involved in cell injury, vascular remodeling, and inflammation. The actions of Ang II could be antagonized by its conversion to the vasodilator peptide Ang (1\u20137), partly generated by the action of angiotensin converting enzyme 2 (ACE2) and\/or neprilysin (NEP). Previous studies demonstrated increased urinary ACE2 shedding in the <jats:italic>db<\/jats:italic>\/<jats:italic>db<\/jats:italic> mouse model of diabetic kidney disease. The aim of the study was to investigate whether renal and urinary ACE2 and NEP are altered in the 2K1C Goldblatt hypertensive mice. Since AT1R is highly expressed in the kidney, we also researched the effect of global deletion of AT1R on renal and urinary ACE2, NEP, and kidney injury marker (KIM-1). Hypertension and albuminuria were induced in AT1R knock out (AT1RKO) and WT mice by unilateral constriction of the renal artery of one kidney. The 24\u00a0h mean arterial blood pressure (MAP) was measured using radio-telemetry. Two weeks after 2K1C surgery, MAP and albuminuria were significantly increased in WT mice compared to AT1RKO mice. Results demonstrated a correlation between MAP and albuminuria. Unlike <jats:italic>db<\/jats:italic>\/<jats:italic>db<\/jats:italic> diabetic mice, ACE2 and NEP expression and activities were significantly decreased in the clipped kidney of WT and AT1RKO compared with the contralateral kidney and sham control (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). There was no detectable urinary ACE2 and NEP expression and activity in 2K1C mice. KIM-1 was significantly increased in the clipped kidney of WT and AT1KO (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Deletion of AT1R has no effect on the increased urinary KIM-1 excretion detected in 2K1C mice. In conclusion, renal injury in 2K1C Goldblatt mouse model is associated with loss of renal ACE2 and NEP expression and activity. Urinary KIM-1 could serve as an early indicator of acute kidney injury. Deletion of AT1R attenuates albuminuria and hypertension without affecting renal ACE2, NEP, and KIM-1 expression.<\/jats:p>","DOI":"10.3389\/fphar.2020.602985","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:35:06Z","timestamp":1611894906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension"],"prefix":"10.3389","volume":"11","author":[{"given":"Laale F.","family":"Alawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana E.","family":"Emberesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshal","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anhar","family":"Hosawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unmesha","family":"Thanekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Grobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M.","family":"Elased","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1470320314551443","article-title":"Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan","volume":"16","author":"Abe","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"B2","unstructured":"Role of angiotensin II type 1 A receptors on renal and urinary angiotensin converting enzyme 2 (ACE2) and neprilysin (NEP) in the two-kidney one- clip (2K1C) model of renovascular hypertension. 2\n            AlawiL. F.\n          2015"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e14364","DOI":"10.14814\/phy2.14364","article-title":"Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db\/db diabetic mice","volume":"8","author":"Alawi","year":"2020","journal-title":"Physiol. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"F335","DOI":"10.1152\/ajprenal.00438.2016","article-title":"The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes","volume":"312","author":"Burns","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/01.HYP.0000036452.28493.74","article-title":"Essential role of AT1A receptor in the development of 2K1C hypertension","volume":"40","author":"Cervenka","year":"2002","journal-title":"Hypertension"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1097\/HJH.0b013e3282fe6eaa","article-title":"Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice","volume":"26","author":"Cervenka","year":"2008","journal-title":"J. Hypertens."},{"key":"B7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1139\/cjpp-2014-0065","article-title":"Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes","volume":"92","author":"Cherney","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e62833","DOI":"10.1371\/journal.pone.0062833","article-title":"Rosiglitazone treatment of type 2 diabetic db\/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion","volume":"8","author":"Chodavarapu","year":"2013","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11906-017-0778-2","article-title":"Intrarenal angiotensin-converting enzyme: the old and the new","volume":"19","author":"Culver","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4239\/wjd.v5.i6.763","article-title":"Biomarkers in diabetic nephropathy: present and future","volume":"5","author":"Currie","year":"2014","journal-title":"World J. Diabetes"},{"key":"B11","first-page":"415","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"33678","DOI":"10.1038\/srep33678","article-title":"Neprilysin is a mediator of alternative renin-angiotensin-system Activation in the murine and human kidney","volume":"6","author":"Domenig","year":"2016","journal-title":"Sci. Rep."},{"key":"B13","first-page":"S308","article-title":"Effect of exercise and rosiglitazone on neprilysin protein expression in db\/db diabetic mice","volume":"56","author":"Elased","year":"2013","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e71433","DOI":"10.1371\/journal.pone.0071433","article-title":"Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury","volume":"8","author":"Fang","year":"2013","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.59.3.347","article-title":"Studies on experimental hypertension\u202f: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia","volume":"59","author":"Goldblatt","year":"1934","journal-title":"J. Exp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0117899","DOI":"10.1371\/journal.pone.0117899","article-title":"Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice","volume":"10","author":"Grobe","year":"2015","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cmet.2011.03.001","article-title":"AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure","volume":"13","author":"Gurley","year":"2011","journal-title":"Cell Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"F263","DOI":"10.1152\/ajprenal.00565.2017","article-title":"Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes","volume":"315","author":"Gutta","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.74.suppl_1.P2036","article-title":"Abstract P2036: effects of angiotensin II type 1 A receptor (AT1aR) on renal and urinary biomarkers of acute kidney injury in two kidney one clip (2K1C) model of renovascular hypertension","volume":"74","author":"Hosawi","year":"2019","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/ndt\/gfu269","article-title":"Neprilysin inhibition in chronic kidney disease","volume":"30","author":"Judge","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000474932","article-title":"Urinary angiotensinogen and renin excretion are associated with chronic kidney disease","volume":"42","author":"Juretzko","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/HYPERTENSIONAHA.111.199588","article-title":"Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism","volume":"61","author":"Karoor","year":"2013","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","first-page":"F195","DOI":"10.1152\/ajprenal.00001.2015","article-title":"Sequential activation of the intrarenal renin-angiotensin system in the progression of hypertensive nephropathy in Goldblatt rats","volume":"311","author":"Kim","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00467-014-2888-2","article-title":"Urinary biomarkers for early diabetic nephropathy: beyond albuminuria","volume":"30","author":"Lee","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000368486","article-title":"Urinary angiotensin converting enzyme 2 increases in patients with type 2 diabetic mellitus","volume":"40","author":"Liang","year":"2015","journal-title":"Kidney Blood Press. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ki.2012.458","article-title":"Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease","volume":"83","author":"Liu","year":"2013","journal-title":"Kidney Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s11255-016-1334-8","article-title":"Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients","volume":"48","author":"Mariana","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"c57","DOI":"10.1159\/000319648","article-title":"Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy","volume":"117","author":"Mizuiri","year":"2011","journal-title":"Nephron Clin. Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ijcard.2016.06.271","article-title":"Serum neprilysin and recurrent hospitalizations after acute heart failure","volume":"220","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/01.HYP.35.2.550","article-title":"Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II","volume":"35","author":"Oliverio","year":"2000","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis","volume":"168","author":"Oudit","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12882-017-0587-5","article-title":"Urinary neprilysin in the critically ill patient","volume":"18","author":"Pajenda","year":"2017","journal-title":"BMC Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2013.05.045","article-title":"Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer\u2019s disease mice","volume":"1529","author":"Park","year":"","journal-title":"Brain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EJE-12-0782","article-title":"High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria","volume":"168","author":"Park","year":"","journal-title":"Eur. J. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1038\/s41598-019-38867-2","article-title":"The circulating form of neprilysin is not a general biomarker for overall survival in treatment-na\u00efve cancer patients","volume":"9","author":"Pavo","year":"2019","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYPERTENSIONAHA.109.139287","article-title":"Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats","volume":"54","author":"Polichnowski","year":"2009","journal-title":"Hypertension"},{"key":"B45","doi-asserted-by":"publisher","first-page":"F749","DOI":"10.1152\/ajprenal.00383.2009","article-title":"Reciprocal changes in renal ACE\/ANG II and ACE2\/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats","volume":"300","author":"Prieto","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/HYPERTENSIONAHA.108.110916","article-title":"Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats","volume":"51","author":"Prieto-Carrasquero","year":"2008","journal-title":"Hypertension"},{"key":"B47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-4615-9546-5_58","article-title":"Localization of neutral endopeptidase in the kidney determined by the stop-flow method","author":"Sakakibara","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"F629","DOI":"10.1152\/ajprenal.00516.2013","article-title":"Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice","volume":"306","author":"Saito","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"F874","DOI":"10.1152\/ajprenal.00209.2017","article-title":"Urinary renin-angiotensin markers in polycystic kidney disease","volume":"313","author":"Salih","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-291X(05)80983-0","article-title":"Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome","volume":"185","author":"Sasamura","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler","year":"2007","journal-title":"Kidney Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/JOE-13-0532","article-title":"Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db\/db diabetic mice","volume":"221","author":"Somineni","year":"2014","journal-title":"J. Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.2175","article-title":"Tubular kidney injury molecule-1 (KIM-1) in human renal disease","volume":"212","author":"van Timmeren","year":"2007","journal-title":"J. Pathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/CS20090318","article-title":"Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition","volume":"118","author":"Velkoska","year":"2010","journal-title":"Clin. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ejhf.232","article-title":"Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction","volume":"17","author":"Voors","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"B57","doi-asserted-by":"publisher","first-page":"F1308","DOI":"10.1152\/ajprenal.00167.2006","article-title":"Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat","volume":"291","author":"Whaley-Connell","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"R891","DOI":"10.1152\/ajpregu.1996.271.4.R891","article-title":"AT1 and TxA2\/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat","volume":"271","author":"Wilcox","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"F600","DOI":"10.1152\/ajprenal.00600.2012","article-title":"Regulation of urinary ACE2 in diabetic mice","volume":"305","author":"Wysocki","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00074.2017","article-title":"Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease","volume":"313","author":"Wysocki","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.hyp.19.6.692","article-title":"In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats","volume":"19","author":"Yamamoto","year":"1992","journal-title":"Hypertension"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1681\/ASN.2014040408","article-title":"Urinary angiotensinogen level predicts aki in acute decompensated heart failure: a prospective, two-stage study","volume":"26","author":"Yang","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes","volume":"17","author":"Ye","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.602985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T10:57:35Z","timestamp":1614077855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.602985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":65,"alternative-id":["10.3389\/fphar.2020.602985"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.602985","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"article-number":"602985"}}